Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Pérez Martínez, Juan ^c   Pérez Martínez, Francisco C ^d   Carrión, Blanca ^d   Masiá, Jesús ^c   Ortega, Agustín ^c   Simarro, Esther ^c   Nam Cha, Syong H ^c   Ceña, Valentín ^a,b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Unidad de Enfermedades Infecciosas   (Spain)

^d Parque Científico y Tecnológico ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMYLOID P COMPONENT; C REACTIVE PROTEIN; COLLAGEN TYPE 3; FIBRONECTIN; GLUCOSE; PERITONEAL DIALYSIS FLUID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; AMIDE; BIOLOGICAL MARKER; FUMARIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MESOTHELIUM CELL; NONHUMAN; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; RAT; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; EPITHELIUM CELL; FIBROSIS; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME; TRANSPORT AT THE CELLULAR LEVEL;

RATTUS;

AMIDES; ANIMALS; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FIBROSIS; FUMARATES; GLUCOSE; INFLAMMATION; MALE; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 84871128440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036268     Document Type: Article

References (38)

1. Bailie GR, Uhlig K, Levey AS, (2005) Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy 25: 491-502.
2. Lameire N, Van BW, (2010) Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6: 75-82.
3. Nagy JA, (1996) Peritoneal membrane morphology and function. Kidney Int Suppl 56: S2-11.
4. Krediet RT, (1999) The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 55: 341-356.
5. Davies SJ, (2004) Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66: 2437-2445.
6. Holmes C, Mujais S, (2006) Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl pp. S104-S109.
7. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B, (1990) Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38: 495-506.
8. Davies SJ, Phillips L, Naish PF, Russell GI, (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051.
9. Mortier S, De Vriese AS, Lameire N, (2003) Recent concepts in the molecular biology of the peritoneal membrane- implications for more biocompatible dialysis solutions. Blood Purif 21: 14-23.
10. Noh H, Ha H, Yu MR, Kim YO, Kim JH, et al. (2005) Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 25: 38-47.
11. Nessim SJ, Perl J, Bargman JM, (2010) The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?. Kidney Int 78: 23-28.
12. Weber KT, Swamynathan SK, Guntaka RV, Sun Y, (1999) Angiotensin II and extracellular matrix homeostasis. Int J Biochem Cell Biol 31: 395-403.
13. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, et al. (2005) Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16: 425-436.
14. Jensen C, Herold P, Brunner HR, (2008) Aliskiren: the first renin inhibitor for clinical treatment. Nat Rev Drug Discov 7: 399-410.
15. Muller DN, Luft FC, (2006) Direct renin inhibition with aliskiren in hypertension and target organ damage. Clin J Am Soc Nephrol 1: 221-228.
16. Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, et al. (2001) Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50: 1472-1481.
17. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, et al. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18: 2004-2013.
18. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, et al. (2008) Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26: 423-428.
19. Gotloib L, (2009) Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress. Contrib Nephrol 163: 35-44.
20. Xu ZG, Kim KS, Park HC, Choi KH, Lee HY, et al. (2003) High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int 63: 958-968.
21. Bozkurt D, Cetin P, Sipahi S, Hur E, Nar H, et al. (2008) The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis. Perit Dial Int 28 (Suppl 5): S38-S42.
22. Singh VP, Baker KM, Kumar R, (2008) Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol 294: H1675-H1684.
23. Lavrentyev EN, Malik KU, (2009) High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs. Am J Physiol Heart Circ Physiol 296: H106-H118.
24. Singh R, Singh AK, Alavi N, Leehey DJ, (2003) Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 14: 873-880.
25. Fusshoeller A, (2008) Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatr Nephrol 23: 19-25.
26. Chaudhary K, Khanna R, (2010) Biocompatible peritoneal dialysis solutions: do we have one? Clin J Am Soc Nephrol 5: 723-732.
27. Westermann D, Riad A, Lettau O, Roks A, Savvatis K, et al. (2008) Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension 52: 1068-1075.
28. Singh VP, Le B, Khode R, Baker KM, Kumar R, (2008) Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57: 3297-3306.
29. Yung S, Thomas GJ, Davies M, (2000) Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 58: 1953-1962.
30. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, et al. (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292.
31. Chung SH, Heimburger O, Lindholm B, Lee HB, (2005) Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 20: 1207-1213.
32. Ke CY, Lee CC, Lee CJ, Subeq YM, Lee RP, et al. (2010) Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats. Eur J Clin Invest 40: 301-309.
33. Carrión B, Pérez-Martínez FC, Monteagudo S, Pérez-Carrión MD, Gómez-Roldán C, et al. (2011) Atorvastatin reduces high glucose toxicity in rat peritoneal mesothelial cells. Perit Dial Int 31: 325-331.
34. Ha H, Yu MR, Choi HN, Cha MK, Kang HS, et al. (2000) Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int 20 (Suppl 5): S10-S18.
35. Simoncini S, Sapet C, Camoin-Jau L, Bardin N, Harle JR, et al. (2005) Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. Int Immunol 17: 489-500.
36. Jordan J, Galindo MF, Calvo S, Gonzalez-Garcia C, Ceña V, (2000) Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. Br J Pharmacol 130: 1496-1504.
37. Posadas I, Vellecco V, Santos P, Prieto-Lloret J, Ceña V, (2007) Acetaminophen potentiates staurosporine-induced death in a human neuroblastoma cell line. Br J Pharmacol 150: 577-585.
38. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.